Actionnariat et activité des initiés pour Biohaven Ltd. (BHVN): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $12.02 |
| Capitalisation | $1.8B |
| Bourse | NYSE |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-06 | Yetimoglu John | |||
| 2026-07-09 | Volles Warren Karl | |||
| 2026-07-09 | Volles Warren Karl | 300,000 | $2.1M | |
| 2026-07-09 | Volles Warren Karl | 78,750 | $2.3M | |
| 2026-07-09 | Volles Warren Karl | 95,250 | $4.0M | |
| 2026-07-09 | Volles Warren Karl | 83,000 | $3.2M | |
| 2026-07-09 | Volles Warren Karl | 175,000 | $2.0M | |
| 2026-07-09 | Volles Warren Karl | 14,000 | ||
| 2026-04-28 | Mehta Kishan | A-Award | 68,693 | $660K |
| 2026-04-28 | Bailey Gregory | A-Award | 68,693 | $660K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $131.5M | $264.2M | $316.7M | $82.5M | $76.1M | $204.9M | $248.4M | $99.1M | $230.0M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | $260.5M | $133.4M | $386.9M | $89.2M |
| Créances | 0 | 0 | 0 | 0 | $9.9M | $46.1M | $13.3M | $2.6M | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $136.7M | $272.3M | $328.3M | $89.8M | $94.8M | $587.0M | $442.4M | $538.5M | $368.3M |
| Immobilisations Corporelles | $2.3M | $6.2M | $8.2M | $13.6M | $18.2M | $52.4M | $48.6M | $53.7M | $16.0M |
| Goodwill | 0 | 0 | 0 | 0 | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M |
| Actifs Incorporels | 0 | 0 | 0 | 0 | $18.4M | $18.4M | $18.4M | $18.4M | $18.4M |
| Actifs Totaux | $146.9M | $290.0M | $344.3M | $111.5M | $142.1M | $661.8M | $513.2M | $615.1M | $451.4M |
| Dettes Fournisseurs | $4.7M | $10.8M | $14.1M | $2.8M | $4.8M | $10.7M | $15.6M | $18.0M | $11.6M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $9.4M | $19.5M | $66.2M | $29.9M | $41.9M | $90.0M | $55.4M | $154.2M | $115.9M |
| Dette à Long Terme | 0 | $117.5M | 0 | 0 | 0 | 0 | 0 | 0 | $238.9M |
| Passifs Totaux | $14.9M | $139.1M | $351.7M | $34.7M | $47.4M | $123.0M | $85.2M | $191.7M | $399.4M |
| Réserves | -$202.6M | -$443.6M | -$972.4M | 0 | 0 | -$91.1M | -$499.3M | -$1.35B | -$2.08B |
| Capitaux Propres | $132.0M | $150.9M | -$7.4M | $16.8M | $34.7M | $538.8M | $428.0M | $423.4M | $52.1M |
| Dette Totale | 0 | $117.5M | 0 | $3.6M | $2.8M | $33.6M | $30.9M | $36.6M | $284.6M |
| Dette Nette | -$131.5M | -$146.7M | -$316.7M | -$78.9M | -$73.3M | -$431.7M | -$350.9M | -$449.4M | -$34.5M |
| Fonds de Roulement | $127.2M | $252.8M | $262.1M | $59.9M | $52.9M | $496.9M | $387.0M | $384.2M | $252.4M |
Santé financière
| Dette / Capitaux propres | 24.30 |
| Ratio de liquidité | 4.73 |
Rentabilité
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ABCL · CLDX · IMCR · IMNM · NTLA · PHVS · SION
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de BHVN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions